Impairment of 11β-hydroxylase but not 21-hydroxylase in adrenal 'incidentalomas'

European Journal of Endocrinology

Volumn 136, Issue 2, 1997, Pages 196-200

  Reincke, Martin ^a   Peter, Michael ^b   Sippell, Wolfgang G ^b   Allolio, Bruno ^a  

^a UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTERONE; CORTODOXONE; DEOXYCORTICOSTERONE; HYDROCORTISONE; HYDROXYPROGESTERONE; PROGESTERONE; STEROID 11BETA MONOOXYGENASE; STEROID 21 MONOOXYGENASE; TETRACOSACTIDE;

ADRENAL TUMOR; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL;

EID: 0031050730     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1360196     Document Type: Article

References (21)

1. Copeland PM. The incidentally discovered adrenal mass. Annals of Internal Medicine 1983 98 940-945.
2. Grilling G. Editorial: A-I-D-S: The new endocrine epidemic. Journal of Clinical Endocrinology and Metabolism 1994 79 1530-1531.
3. Ross NS & Aron DC. Hormonal evaluation of the patient with an incidentally discovered adrenal mass. New England Journal of Medicine 1990 323 1401-1405.
4. Hensen J, Buhl M & Oelkers W. Diagnostisches und therapeutisches Vorgehen bei Patienten mit zufällig entdeckten Nebennierentumoren. In Moderne Diagnostik und Therapeutische Strategien bei Nebennierenerkrankungen, pp 210-215. Eds B Allolio & HM Schulte. Stuttgart: Schattauer, 1990.
5. Hensen J, Buhl M, Bähr V & Oelkers W. Endocrine activity of the 'silent' adrenocortical adenoma is uncovered by response to corticotropin-releasing hormone. Klinische Wochenschrift 1990 68 608-614.
6. Reincke M, Winkelmann W, Jaursch-Hancke C, Kaulen D, Nicke J, Ollenschläger G & Allolio B. Diagnostik und Therapie des Nebenniereninzidentaloms. Deutsche Medizinische Wochenschrift 1989 114 861.
7. Reincke M, Nicke J, Krestin GP, Saeger W, Allolio B & Winkelmann W. Preclinical Cushing's syndrome in patients with adrenal 'incidentalomas': comparison with adrenal Cushing's syndrome. Journal of Clinical Endocrinology and Metabolism 1992 75 826-832.
8. Osella G, Terzollo M, Boretta M, Magro G, Ali A, Piovesan A, Paccotti P & Angeli A. Endocrine evaluation of incidentally discovered adrenal masses (incidentalomas). Journal of Clinical Endocrinology and Metabolism 1994 79 1532-1539.
9. Terzolo M, Osella G, Ali A, Boretta M, Magro G, Piovesan A et al. Different patterns of steroid secretion in patients with adrenal incidentalomas. Journal of Clinical Endocrinology and Metabolism 1996 81 740-744.
10. Flecchia D, Mazza E, Carlini M, Blatto A, Olivieri F, Serra G, Camanni F & Messina M. Reduced serum levels of dehydroepiandrosterone sulphate in adrenal incidentalomas: a marker of adrenocortical tumor. Clinical Endocrinology 1995 42 129-134.
11. Reincke M, Allolio B, Würth G, Jaursch-Hancke C, Nieke J & Winkelmann W. Spielt die Heterozygotie für den 21-Hydroxylase-Mangel eine Rolle in der Pathogenese asymptomatischer Nebennierentumoren? Klinische Wochenschrift 1990 68 (Suppl 19) 321.
12. Seppel T & Schlaghecke R. Augmented 17-alpha-hydroxyprogesterone response to ACTH stimulation as evidence of decreased 21-hydroxylase activity in patients with incidentally discovered adrenal 'incidentalomas'. Clinical Endocrinology 1994 41 445.
13. New MI, Lorenzen F, Lerner AJ, Kohn B, Oberfield SE, Pollack MS et al. Genotyping steroid 21-hydroxylase deficiency: Hormonal reference data. Journal of Clinical Endocrinology and Metabolism 1983 57 320-326.
14. Eldar-Geva T, Hurwitz A, Vecsei P, Palti Z, Milwidsky A & Rösler A. Secondary biosynthetic defects in women with late-onset congenital adrenal hyperplasia. New England Journal of Medicine 1990 323 855-863.
15. Peter M, Sippell WG, Lorenzen F, Willig RP, Westphal E & Grosse-Wilde H. Improved test to identify heterozygotes for congenital adrenal hyperplasia without index case examination. Lancet 1990 335(i) 1296-1299.
16. Sippell WG, Bidlingmaier F, Becker H, Brünig T, Dörr H, Hahn H, Goldner W, Hollmann G & Knorr D. Simultaneous radioimmunoassay of plasma aldosterone, corticosterone, 11-deoxycortisol, progesterone, 17-hydroxyprogesterone, 11-deoxycortisol, cortisol and cortisone. Journal of Steroid Biochemistry 1978 9 63-74.
17. Jaresch S, Kornely E, Kley HK & Schlaghecke R. Adrenal incidentaloma and patients with homozygous or heterozygous congenital adrenal hyperplasia. Journal of Clinical Endocrinology and Metabolism 1992 74 685-689.
18. Mauthe I, Laspe H & Knorr D. Zur Häufigkeit des kongenitalen adrenogenitalen Syndroms (AGS): München 1963-1972. Klinische Pädiatrie 1977 189 172-176.
19. Jaresch S, Schlaghecke R, Jungblut R, Krüskemper HL & Kley HK. Stumme Nebennierentumoren bei Patienten mit adrenogenitalem Syndrom. Klinische Wochenschrift 1987 65 627-633.
20. Doerr HG, Sippell WG, Drop SL, Bidlingmaier F & Knorr D. Evidence of 11-beta-hydroxylase deficiency in childhood adrenocortical tumors. The plasma corticosterone/11-deoxycorticosterone ratio as a possible marker for malignancy. Cancer 1987 60 1625-1629.
21. Aupetit-Faisant B, Battaglia C, Zenatti M, Emeric-Blanchoin N & Legrand JC. Hypoaldosteronism accompanied by normal or elevated mineralocorticoid pathway steroid: A marker of adrenal carcinoma. Journal of Clinical Endocrinology and Metabolism 1993 76 38-43.